文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

寿惠通便胶囊对慢传输型便秘模型小鼠的治疗作用及机制

[Therapeutic effect and mechanism of Shouhui Tongbian Capsules on slow transit constipation model mice].

作者信息

Zheng Shu-Ze, Guo Qiang, Zhang Gui-Min, Pan Li-Hong, Zeng Ke-Wu

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Beijing 100191, China.

State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Co., Ltd. Linyi 276006, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2021 Feb;46(3):520-525. doi: 10.19540/j.cnki.cjcmm.20201125.401.


DOI:10.19540/j.cnki.cjcmm.20201125.401
PMID:33645015
Abstract

Shouhui Tongbian Capsules was used to explore the therapeutic effect and potential mechanism on slow transit constipation model mice induced by loperamide hydrochloride. In the experiment, loperamide hydrochloride-induced ICR mice were used as the model of slow transit constipation. Fifty ICR mice were divided into the blank group, model group and high, medium and low dose groups of Shouhui Tongbian Capsules extract(100, 200 and 400 mg·kg~(-1)). The model group and the administration groups were then modeled using loperamide hydrochloride intragastrically to obtain slow transit constipation. After successful modeling, high, medium and low doses of drugs were given to each drug group by intragastric administration. After 14 days of administration, the first defecation time, 6 h defecation grain number, 6 h defecation wet weight and dry weight, black feces discharged within 6 h and the fecal water content were measured. Intestinal tissues were taken for c-Kit and SCF immunohistochemical sections to detect the expression of c-Kit and SCF in the blank group, model group and high, medium and low dose groups of the medicinal extract of Shouhui Tongbian Capsules. The tissue changes in the intestinal wall of mice were detected by HE staining. At the same time, partial intestinal tissues were taken to test the activity of ATP synthase and isocitrate dehydrogenase in intestinal tissues of mice. RESULTS:: showed that Shouhui Tongbian Capsules effectively improved the symptoms of slow transit constipation in ICR mice and promoted intestinal movement. Shouhui Tongbian Capsules obviously shortened the time of discharging black stool for the first time, improved the intestinal propulsion rate, increased the water content and amount of feces, and improved the constipation symptoms. Mechanism study revealed that Shouhui Tongbian Capsules increased ATP synthase activity and mitochondrial isocitrate dehydrogenase activity in intestinal tissue, and up-regulated c-Kit/SCF signaling pathway to promote interstitial Cajal cells proliferation, intestinal nerve transmission, intestinal motility and transport capacity.

摘要

寿辉通便胶囊用于探讨其对盐酸洛哌丁胺诱导的慢传输型便秘模型小鼠的治疗作用及潜在机制。实验中,将盐酸洛哌丁胺诱导的ICR小鼠作为慢传输型便秘模型。50只ICR小鼠分为空白组、模型组以及寿辉通便胶囊提取物高、中、低剂量组(100、200和400mg·kg⁻¹)。然后对模型组和给药组小鼠进行盐酸洛哌丁胺灌胃造模,以获得慢传输型便秘。造模成功后,对各给药组分别进行高、中、低剂量药物灌胃给药。给药14天后,测量首次排便时间、6小时排便粒数、6小时排便湿重和干重、6小时内排出的黑便量以及粪便含水量。取肠道组织进行c-Kit和SCF免疫组化切片,检测寿辉通便胶囊药物提取物空白组、模型组以及高、中、低剂量组中c-Kit和SCF的表达。通过HE染色检测小鼠肠壁的组织变化。同时,取部分肠道组织检测小鼠肠道组织中ATP合酶和异柠檬酸脱氢酶的活性。结果显示:寿辉通便胶囊有效改善了ICR小鼠慢传输型便秘症状,促进了肠道蠕动。寿辉通便胶囊明显缩短了首次排出黑便的时间,提高了肠道推进率,增加了粪便含水量和量,改善了便秘症状。机制研究表明,寿辉通便胶囊增加了肠道组织中ATP合酶活性和线粒体异柠檬酸脱氢酶活性,上调了c-Kit/SCF信号通路,以促进间质 Cajal 细胞增殖、肠道神经传导、肠道蠕动和运输能力。

相似文献

[1]
[Therapeutic effect and mechanism of Shouhui Tongbian Capsules on slow transit constipation model mice].

Zhongguo Zhong Yao Za Zhi. 2021-2

[2]
[Molecular mechanism study of Shouhui Tongbian Capsules on promoting energy metabolism of gastrointestinal stromal cells].

Zhongguo Zhong Yao Za Zhi. 2021-2

[3]
[Metabonomics study of Shouhui Tongbian Capsules in slow transit constipation based on UPLC-ESI-QE-Orbitrap-MS].

Zhongguo Zhong Yao Za Zhi. 2021-2

[4]
[Mechanism of Shouhui Tongbian Capsules in treating constipation based on network pharmacology and molecular docking].

Zhongguo Zhong Yao Za Zhi. 2021-2

[5]
Shouhui Tongbian Capsules induce regression of inflammation to improve intestinal barrier in mice with constipation by targeted binding to Prkaa1: With no obvious toxicity.

Biomed Pharmacother. 2023-5

[6]
Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis.

Biomed Pharmacother. 2022-10

[7]
[Identification of intestine direct targets of Shouhui Tongbian Capsules using "target fishing" strategy].

Zhongguo Zhong Yao Za Zhi. 2021-2

[8]
Chinese patent medicine shouhui tongbian capsule attenuated loperamide-induced constipation through modulating the gut microbiota in rat.

J Ethnopharmacol. 2022-11-15

[9]
Therapeutic effect of on defecation in senile constipation rat model through stem cell factor/C-kit signaling pathway.

World J Gastroenterol. 2021-8-28

[10]
Efficacy and safety of Shouhui Tongbian Capsules in the treatment of constipation: A systematic review and meta-analysis.

Phytomedicine. 2023-1

引用本文的文献

[1]
Unveiling Xuanshen decoction: A novel approach to combat slow transit constipation.

World J Gastroenterol. 2025-8-14

[2]
Shouhui Tongbian Capsule in treatment of constipation: Treatment and mechanism development.

Chin Herb Med. 2023-11-21

[3]
Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic.

BMC Microbiol. 2023-5-20

[4]
Xuanhuang Runtong Tablets Relieve Slow Transit Constipation in Mice by Regulating TLR5/IL-17A Signaling Mediated by Gut Microbes.

Evid Based Complement Alternat Med. 2023-1-16

[5]
Furu2019 and stachyose as probiotics, prebiotics, and synbiotics alleviate constipation in mice.

Front Nutr. 2023-1-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索